7 completed, 2 recruiting, 2 terminated, 2 unknown. 7 Phase 2, 5 Phase 3, 2 Phase 1, 2 Phase 4, 1 Early Phase 1.
Follow prednisolone phosphate: new trials by email Literature Review of prednisolone phosphate trials Research Report on prednisolone phosphate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combination Therapy With Danazol, Prednisolone, and Thalidomide for Thalidomide-Refractory Transfusion-Dependent β-Thalassemia Thalidomide, Danazol, Prednisolone - Beta-Thalassemia, Thalassemia | Phase 3 | Recruiting | Khyber Medical University Peshawar | 172 | 2026-10-12 | 2026-10-21 |
| Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age Prednisolone Sodium Phosphate, Sugar syrup - Bronchiolitis Acute Viral | Phase 4 | Recruiting | University of Oulu | 210 | 2022-10-11 | 2025-02-13 |
| Nivolumab With Standard of Care Chemotherapy for Peripheral T Cell Lymphomas Nivolumab, Etoposide, Prednisolone - Peripheral T Cell Lymphoma | Phase 1 / Phase 2 | Completed | University of Colorado, Denver | 18 | 2018-11-07 | 2024-10-29 |
| The Efficacy of Nasal Steroids in Treatment of Otitis Media With Effusion: Acomparative Study Mometasone Furoate spray, prednisolone sodium phosphate 15mg, hypertonic sea water solution spray - Otitis Media With Effusion | Early Phase 1 | Unknown | Muteea Mubark Salmen Bakuwiri | 60 | 2018-05-15 | 2018-04-18 |
| Parasitic Ulcer Treatment Trial Pilot Chlorhexidine, Povidone-Iodine, Prednisolone Sodium Phosphate - Acanthamoeba Keratitis | Phase 2 | Completed | University of California, San Francisco | 49 | 2018-01-01 | 2026-05-07 |
| Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma Prednisone, Vincristine, Daunorubicin - Acute Lymphoblastic Leukemia, Acute Lymphoblastic Lymphoma | Phase 2 / Phase 3 | Active not recruiting | St. Jude Children's Research Hospital | 790 | 2017-03-29 | 2026-06-17 |
| Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCL Tazemetostat, Prednisolone - B-cell Lymphomas (Phase 1), Advanced Solid Tumors (Phase 1) | Phase 1 / Phase 2 | Completed | Epizyme, Inc. | 400 | 2013-06-13 | 2024-03-26 |
| Single Dose Oral Dexamethasone Versus Multi-dose Prednisolone in the Treatment of Acute Exacerbations of Asthma in Children Prednisolone Sodium Phosphate, Dexamethasone - Asthma, Acute Asthma | Phase 4 | Completed | University College Dublin | 250 | 2011-07-06 | 2018-10-09 |
| Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas propranolol, Prednisolone - Hemangioma of Infancy | Phase 2 | Terminated | Nancy Bauman | 19 | 2009-07-01 | 2016-02-24 |
| Cyclophosphamide, Rituximab, and Either Prednisone or Methylprednisolone in Treating Patients With Lymphoproliferative Disease After Solid Organ Transplantation rituximab, cyclophosphamide, methylprednisolone - Lymphoproliferative Disorder | Phase 2 | Completed | Children's Oncology Group | 55 | 2004-04-01 | 2019-08-06 |
| A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years bleomycin sulfate, cyclophosphamide, etoposide - Lymphoma | Phase 2 | Completed | Newcastle-upon-Tyne Hospitals NHS Trust | 175 | 2004-01-01 | 2017-03-30 |
| Efficacy of Infliximab in the Treatment of Patients Affected by Corticodependent Crohn's Disease (P02732) Infliximab, AZA, Placebo Prednisolone - Crohn's Disease | Phase 3 | Terminated | Merck Sharp & Dohme LLC | 9 | 2003-11-01 | 2017-03-23 |
| Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma asparaginase, cyclophosphamide, cytarabine - Lymphoma | Phase 3 | Completed | Children's Oncology Group | 393 | 2000-06-01 | 2019-08-06 |
| Herpetic Eye Disease Study (HEDS) I Prednisolone Phosphate, Acyclovir - Keratitis, Herpetic, Ocular Herpes Simplex | Phase 3 | Unknown | National Eye Institute (NEI) | 1989-05-01 | 2009-09-17 |
Lymphoma (3) · Acanthamoeba Keratitis (1) · Asthma (1) · Crohn Disease (1) · Emergencies (1) · Hemangioma (1) · Hodgkin Disease (1) · Keratitis, Herpetic (1) · Leukemia (1) · Lymphoma, B-Cell (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, T-Cell, Peripheral (1) · Lymphoproliferative Disorders (1) · Otitis Media with Effusion (1)
Children's Oncology Group (2) · Epizyme, Inc. (1) · Khyber Medical University Peshawar (1) · Merck Sharp & Dohme LLC (1) · Muteea Mubark Salmen Bakuwiri (1) · Nancy Bauman (1) · National Eye Institute (NEI) (1) · Newcastle-upon-Tyne Hospitals NHS Trust (1) · St. Jude Children's Research Hospital (1) · University College Dublin (1) · University of California, San Francisco (1) · University of Colorado, Denver (1) · University of Oulu (1)
United States (6) · Australia (4) · Canada (3) · Germany (2) · United Kingdom (2) · Finland (1) · France (1) · India (1) · Ireland (1) · Italy (1) · New Zealand (1) · Pakistan (1) · Poland (1) · Puerto Rico (1) · Switzerland (1)
Brad Haverkos, MD (1) · Ezzat M Saleh, Professor (1) · Gulab Fatima Rani, MBBS, PhD (1) · Helen H. Lucraft, MD (1) · Hiroto Inaba, MD, PhD (1) · Jeremy D Keenan, MD (1) · Katrina M. Wood, MD (1) · Minnie Abromowitch, MD (1) · Mohamed M Abd ElNaeem, doctor (1) · Nancy M Bauman, MD (1) · Stephen J. Proctor, MD (1) · Syeda Nayab Imtiaz, MBBS (1) · Thomas G. Gross, MD, PhD (1) · Yasar Mehmood Yousafzai, PhD (1)
PMID 18618503, PMID 19546402, PMID 21320979, PMID 21688345, PMID 22488718, PMID 22883417, PMID 22994934, PMID 24347141, PMID 24526257, PMID 29650362, PMID 33035457, PMID 37981564, PMID 39563886, PMID 41914638, PMID 42154791
U10CA098543 (1)